Keystone Symposia

US Government Grants


Grants from government agencies, departments and institutes for conferences in 2023 and 2022

Government support is crucial to Keystone Symposia's ability to recruit outstanding speakers, and to support student and postdoctoral scholarships. We gratefully acknowledge the generous support provided by the U.S. National Institutes of Health (NIH) and other government agencies:

2023 Conferences



National Cancer Institute (NCI)

Grant No. 1R13CA265047-01A1: Tumor Metabolism - RESCHEDULED (2023-RJ2)
Grant No. 1 R13 CA257245-01: Exosomes, Microvesicles and Other Extracellular Vesicles - RESCHEDULED (2023-RB3)
Grant No. 1R13CA275175-01: Protein-RNA Interactions (2023-J8)

National Center for Advancing Translational Sciences (NCATS)

Grant No. 1R13TR003159-01: Targeted Protein Degradation - RESCHEDULED (2023-RJ6)
Grant No. 1 R13 AI167430-01: Novel Approaches Against Emerging Antimicrobial Resistance - RESCHEDULED (2023-RQ4)*
Grant No. 1R13NS129216-01: Drug Delivery to the Brain: Challenges and Progress (2023-A1)*
Grant No. 1R13Al172245-01: Next Generation Antibody Therapeutics: From Discovery to Patient (2023-Q5)*

National Heart, Lung, and Blood Institute (NHLBI)

Grant No. 1R13HL154588-01: Heart Failure: Mechanisms and Therapies - RESCHEDULED (2023-RQ7)
Grant No. 1R13HL154801-01: Mitochondria, Metabolism and Heart - RESCHEDULED (2023-RQ8)
Grant No. 1 R13 HL156442-01A1: Sleep and Circadian Biology - Maintaining Tempo for Optimal Health (2023-S2)

National Institute of Allergy and Infectious Diseases (NIAID)

Grant No. 1 R13 AI167433-01: A Research Reboot of Tuberculosis on the Keystone Symposia 50th Anniversary - RESCHEDULED (2023-RA3)
Grant No. 1 R13 AI167431-01: Immunometabolism at the Crossroads of Obesity and Cancer - RESCHEDULED (2023-RJ1)
Grant No. 1R13A1172250-01: Neuroimmunometabolism - Obesity at the Crossroads between Neuroimmunity and Immunometabolism (2023-J1)
Grant No. 1 R13 AI167434-01: The Human Microbiome: Ecology and Evolution - RESCHEDULED (2023-RQ3)
Grant No. 1 R13 AI167430-01: Novel Approaches Against Emerging Antimicrobial Resistance - RESCHEDULED (2023-RQ4)
Grant No. 1R13Al172248-01: Inborn Errors of Immunity: From Genetics to Basic Immunological Principles to Therapy (2023-EK1)
Grant No. 1R13AI154970-01: Vector Biology: Emerging Concepts and Novel Technologies (2023-Q4)
Grant No. 1R13Al172245-01: Next Generation Antibody Therapeutics: From Discovery to Patient (2023-Q5)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Grant No. 1R13AR078065-01: Skin-Immune Crosstalk (2023-Q3)
Grant No. 1R13AI154970-01: Vector Biology: Emerging Concepts and Novel Technologies (2023-Q4)*

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Grant No. 1 R13 DK131814-01: Inter Organ Crosstalk in Non-Alcoholic Steatohepatitis (NASH) - RESCHEDULED (2023-RQ1)
Grant No. 1 R13 DK131815-01: Adipose Tissue and Metabolic Health - RESCHEDULED (2023-RQ2)
Grant No. 1 R13 AI167431-01: Immunometabolism at the Crossroads of Obesity and Cancer - RESCHEDULED (2023-RJ1)*
Grant No. 1R13A1172250-01: Neuroimmunometabolism - Obesity at the Crossroads between Neuroimmunity and Immunometabolism (2023-J1)*

National Institute of Mental Health (NIMH)

Grant No. 1R13MH131314-01: Neurocircuitry of Social Behavior (2023-S1)

National Institute of Neurological Disorders and Stroke (NINDS)

Grant No. 1R13NS129216-01: Drug Delivery to the Brain: Challenges and Progress (2023-A1)


2022 Conferences



Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Grant No. 1R13HD108940-01: Organoids as Tools for Fundamental Discovery and Translation (2022-X8)
Grant No. 1R13HD108893-01: Micropeptides: Biogenesis and Function (2022-T5)

National Cancer Institute (NCI)

Grant No. 1 R13 CA257521-01A1: Cancer Immunotherapy: Decoding the Cancer Immunity Interactome (2022-C1)
Grant No. 1 R13 CA257240-01: Cancer: Aging in the Driver's Seat (2022-C4)
Grant No. 1R13CA271453-01: Small Regulatory RNAs: From Bench to Bedside (2022-E1)
Grant No. 1R13CA261004-01: Cancer Neoantigens, Vaccines and Viruses - RESCHEDULED (2022-RT3)

National Center for Advancing Translational Sciences (NCATS)

Grant No. 1R13EB033176-01: Engineering Multi-Cellular Living Systems (2022-X7)*
Grant No. 1R13HD108940-01: Organoids as Tools for Fundamental Discovery and Translation (2022-X8)*
Grant No. 1R13AI169793-01: Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases (2022-D3)*
Grant No. 1 R13 TR004036-01: Precision Genome Engineering - RESCHEDULED (2022-RQ5)
Grant No. 1 R13 TR004225-01: Modern Phenotypic Drug Discovery: From Chemical Biology to Therapeutics (2022-E2)

National Human Genome Research Institute (NHGRI)

Grant No. 1R13HG010979-01: Higher-Order Chromatin Architecture in Time and Space (2022-EK2)
Grant No. 1R13HG012151-01: Gene Regulation: From Emerging Technologies to New Models - RESCHEDULED (2022-RA1)

National Institute of Allergy and Infectious Diseases (NIAID)

Grant No. 1 R13 AI152254-01: Maternal-Fetal Newborn Immunity (2022-EK1)
Grant No. 1 R13 AI167432-01: Innate Immune Memory: From Evolutionary Roots to Human Disease (2022-X3)
Grant No. 1 R13 AI167429-01: Myeloid Cells: From Birth to Immunity and Disease (2022-X4)
Grant No. 1 R13 AI157805-01: Next Generation HIV Vaccines & Therapies (2022-C2)
Grant No. 1R13AI169733-01: Innate Immunity: Complement and Beyond (2022-D1)
Grant No. 1R13AI169927-01: B Cell-T Cell Collaboration: Regulation and Dysregulation (2022-T4)
Grant No. 1R13AI169931-01: Malaria: Confronting Challenges From Drug Discovery to Treatment (2022-D2)
Grant No. 1R13AI169793-01: Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases (2022-D3)
Grant No. 1R13AI154980-01: Antibodies as Drugs - RESCHEDULED (2022-RJ7)
Grant No. 1R13AI169935-01: Progress in Vaccine Development for Infectious Diseases (2022-T8)
Grant No. 1R13AI169926-01: Resolution of Inflammation (2022-Z3)
Grant No. 1R13AI154971-01: Viral Immunity: Basic Mechanisms and Therapeutic Applications - RESCHEDULED (2022-RJ3)
Grant No. 1R13AI154969-01: Respiratory Viruses: New Frontiers - RESCHEDULED (2022-RJ4)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Grant No. 1R13AI169733-01: Innate Immunity: Complement and Beyond (2022-D1)*
Grant No. 1R13AR081059-01: Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies (2022-Z4)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Grant No. 1R13HG010979-01: Higher-Order Chromatin Architecture in Time and Space (2022-EK2)*
Grant No. 1R13EB033176-01: Engineering Multi-Cellular Living Systems (2022-X7)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Grant No. 1R13DK132923-01: Neuronal Control of Appetite (2022-X5)
Grant No. 1R13DK132925-01: Gut-Brain Axis (2022-X6)

National Institute on Aging (NIA)

Grant No. 1R13AR081059-01: Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies (2022-Z4)*

Office of the Director (OD)

Grant No. 1 R13 TR004036-01: Precision Genome Engineering - RESCHEDULED (2022-RQ5)*


* Indicates Secondary Funding Institute for Grant